Medincell SA
PAR:MEDCL

Watchlist Manager

Medincell SA

PAR:MEDCL

Watchlist

Discount Rate

Price: 13.94 EUR -6.82% Market Closed

Updated: Jun 16, 2024

Have any thoughts about
Medincell SA?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

Medincell SA

What unique competitive advantages
does Medincell SA hold over its rivals?

What risks and challenges
does Medincell SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Medincell SA.

What unique competitive advantages
does Medincell SA hold over its rivals?

What risks and challenges
does Medincell SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medincell SA.

Provide P/S
for Medincell SA.

Provide P/E
for Medincell SA.

Provide P/OCF
for Medincell SA.

Provide P/FCFE
for Medincell SA.

Provide P/B
for Medincell SA.

Provide EV/S
for Medincell SA.

Provide EV/GP
for Medincell SA.

Provide EV/EBITDA
for Medincell SA.

Provide EV/EBIT
for Medincell SA.

Provide EV/OCF
for Medincell SA.

Provide EV/FCFF
for Medincell SA.

Provide EV/IC
for Medincell SA.

Show me price targets
for Medincell SA made by professional analysts.

What are the Revenue projections
for Medincell SA?

How accurate were the past Revenue estimates
for Medincell SA?

What are the Net Income projections
for Medincell SA?

How accurate were the past Net Income estimates
for Medincell SA?

What are the EPS projections
for Medincell SA?

How accurate were the past EPS estimates
for Medincell SA?

What are the EBIT projections
for Medincell SA?

How accurate were the past EBIT estimates
for Medincell SA?

Compare the revenue forecasts
for Medincell SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medincell SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medincell SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medincell SA compared to its peers.

Compare the P/E ratios
of Medincell SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medincell SA with its peers.

Analyze the financial leverage
of Medincell SA compared to its main competitors.

Show all profitability ratios
for Medincell SA.

Provide ROE
for Medincell SA.

Provide ROA
for Medincell SA.

Provide ROIC
for Medincell SA.

Provide ROCE
for Medincell SA.

Provide Gross Margin
for Medincell SA.

Provide Operating Margin
for Medincell SA.

Provide Net Margin
for Medincell SA.

Provide FCF Margin
for Medincell SA.

Show all solvency ratios
for Medincell SA.

Provide D/E Ratio
for Medincell SA.

Provide D/A Ratio
for Medincell SA.

Provide Interest Coverage Ratio
for Medincell SA.

Provide Altman Z-Score Ratio
for Medincell SA.

Provide Quick Ratio
for Medincell SA.

Provide Current Ratio
for Medincell SA.

Provide Cash Ratio
for Medincell SA.

What is the historical Revenue growth
over the last 5 years for Medincell SA?

What is the historical Net Income growth
over the last 5 years for Medincell SA?

What is the current Free Cash Flow
of Medincell SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medincell SA.

MEDCL

Cash Flow Statement

Cash from Financing Activities

Medincell SA
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Medincell SA
Cash from Financing Activities Peer Comparison

Comparables:

SAN

IPN

VETO

VIRP

BOI

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

	Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Medincell SA PAR:MEDCL	Cash from Financing Activities €1.6m	CAGR 3-Years -24%	CAGR 5-Years -28%	CAGR 10-Years N/A
Sanofi SA PAR:SAN	Cash from Financing Activities -€8.1B	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Ipsen SA PAR:IPN	Cash from Financing Activities -€458.4m	CAGR 3-Years -14%	CAGR 5-Years -18%	CAGR 10-Years -20%
Vetoquinol SA PAR:VETO	Cash from Financing Activities -€15.5m	CAGR 3-Years N/A	CAGR 5-Years 0%	CAGR 10-Years -1%
Virbac SA PAR:VIRP	Cash from Financing Activities -€2.7m	CAGR 3-Years 80%	CAGR 5-Years 43%	CAGR 10-Years N/A
Boiron SA PAR:BOI	Cash from Financing Activities -€198.4m	CAGR 3-Years -110%	CAGR 5-Years -17%	CAGR 10-Years -28%

What is Medincell SA's Cash from Financing Activities?

Cash from Financing Activities
1.6m EUR

Based on the financial report for Mar 31, 2023, Medincell SA's Cash from Financing Activities amounts to 1.6m EUR.

What is Medincell SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-28%

The average annual Cash from Financing Activities growth rates for Medincell SA have been -24% over the past three years , -28% over the past five years .

Medincell SA
PAR:MEDCL

Medincell SA
Cash from Financing Activities

Medincell SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Medincell SA's Cash from Financing Activities?

Cash from Financing Activities
1.6m EUR

What is Medincell SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-28%

Company

Help

Tools

Stocks

Medincell SA PAR:MEDCL

Medincell SA Cash from Financing Activities

Medincell SA Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Medincell SA's Cash from Financing Activities? Cash from Financing Activities 1.6m EUR

What is Medincell SA's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 5Y -28%

Company

Help

Tools

Stocks

Medincell SA
PAR:MEDCL

Medincell SA
Cash from Financing Activities

Medincell SA
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is Medincell SA's Cash from Financing Activities?

Cash from Financing Activities
1.6m EUR

What is Medincell SA's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-28%